No Data
No Data
Joinn Laboratories (06127): One warning of profit decline has become a market indicator. Will "rate cut" be the final key for valuation rebound?
On July 10, Joinn Laboratories (06127) closed at a record low of HK$6.62. However, the company received a boost after the release of a profit warning that evening. According to the AI Finance and Economics app, on the evening of July 10, Joinn Laboratories issued a profit warning, expecting revenue of approximately 0.719 billion yuan to 0.973 billion yuan (RMB, same below) from January to June 2024. Compared with the same period last year, it will decrease by about 38.6417 million yuan to 0.293 billion yuan, a year-on-year decline of about 3.8% to 28.9%.
JOINN Laboratories (China) Flags Losses in H1; Shares Rise 10%
JOINN Laboratories(China) (HKG:6127, SHA:603127) expects a net loss attributable to the shareholders of 136.3 million yuan to 184.4 million yuan, compared with a profit of 90.6 million yuan in the
Nomura Adjusts Joinn Laboratories' Price Target to 12.27 Yuan From 17.37 Yuan, Keeps at Neutral
Joinn Laboratories (SHA:603127) has an average rating of outperform and price targets ranging from 10 yuan to 21.50 yuan, according to analysts polled by Capital IQ.Price (RMB): ¥13.71, Change: ¥+1.25
Hong Kong stock market active | CXO concept stocks rebounded in early trading, overseas loosening is expected to drive investment and financing to pick up, and there are frequent policies supporting innovative drugs.
CXO Concept Stocks rebounded in early trading, and as of the time of publication, Joinn Laboratories (06127) rose 10.73%, to HKD 7.33; Genscript Bio (01548) rose 5.19%, to HKD 9.53; Pharmaron (03759) rose 5.13%, to HKD 8.6; Tigermed (03347) rose 4.56%, to HKD 28.65.
Hong Kong stocks are fluctuating | Joinn Laboratories (06127) rose more than 6%, with a expected net loss of about 0.136 billion yuan to 0.184 billion yuan in the first half.
Joinn Laboratories (06127) rose over 6%. As of press time, it increased by 6.65%, with a price of HKD 80.50 and a turnover of 5.129 million Hong Kong dollars.
Joinn Laboratories 1H23 Revenue Was CNY1.01B; Net CNY90.63M >603127.SH
Joinn Laboratories 1H23 Revenue Was CNY1.01B; Net CNY90.63M >603127.
No Data